<collection><source>PMC</source><date>20210514</date><key>pmc.key</key><document><id>35352</id><infon key="license">NO-CC CODE</infon><passage><infon key="article-id_doi">10.1186/1471-213X-1-12</infon><infon key="article-id_pmc">35352</infon><infon key="article-id_pmid">11476669</infon><infon key="article-id_publisher-id">1471-213X-1-12</infon><infon key="fpage">12</infon><infon key="journal-title">BMC Developmental Biology</infon><infon key="lpage">12</infon><infon key="name_0">surname:Miyoshi;given-names:Kazuchika</infon><infon key="name_1">surname:Rzucidlo;given-names:S Jacek</infon><infon key="name_2">surname:Gibbons;given-names:John R</infon><infon key="name_3">surname:Arat;given-names:Sezen</infon><infon key="name_4">surname:Stice;given-names:Steven L</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">1</infon><infon key="year">2001</infon><offset>0</offset><text>Development of porcine embryos reconstituted with somatic cells and enucleated metaphase I and II oocytes matured in a protein-free medium</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>139</offset><text>What is the background on this?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>150</offset><text>Different cells have been transferred to enucleated M II oocytes during the early stages of the cell cycle, leading to many cloned animals. Due to the high activity of these cells at different times in the maturation phase, M I ovary may also reprogram their nuclei.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>734</offset><text>What are the outcomes?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>742</offset><text>Analysis of the cell cycle stages showed that 91.2  0.2% of confluent cells were at the G0/G1 phase and 54.1 - 4.4% of nocodazole-treated cells are atthe G2/M phase, respectively; nuclear swelling was recorded in 50.0-88.9% and 34.4-39.5% of embryos reconstituted with contigent (6.1%) and all other donors for 6 h after activation determined to have neither a swollen nucleus nor any polar body culture confirmed this as the percentage is statistically small (P</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1644</offset><text>Remarkable conclusions</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1656</offset><text>After nuclear transfer, somatic cells from porcine M I oocytes may develop into blastocysts.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1762</offset><text>In the world of animal research, the term 'developmental reseach' refers to the study of the development of animals from embryonic stem cells. Such studies are usually done on animals with normal or normal-to-severe genetic abnormalities and are used to better understand the genetic basis of disease.

The term 'developmental reseach' is also sometimes used to refer to the following studies:

The development of human embryos from pluripotent stem cells (HSPCs) is another area in which the term 'developmental reseach' is used to refer to studies in which a pluripotent stem cell (PSC) is used.

What is a pluripotent stem cell?

A pluripotent</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1773</offset><text>M II oocytes have been used as the recipient cytoplasm for many animals cloned with human donors, including sheep, cattle, and goat.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>5254</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>5262</offset><text>Cell Cycle Analysis of Donor Cells</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>5297</offset><text>The cell cycle stages of ear fibroblasts after reaching confluence or treatment with nocodazole were analyzed using flow cytometry. Analysis of the cell cycle stages in confluent cells revealed that 91.2 &#177; 0.2% of the cells were at the G0/G1 phase, 2.5 &#177; 0.1% were at the S phase and 6.4 &#177; 0.1% were at the G2/M phase. In the population of cells collected after nocodazole treatment, 31.0 &#177; 3.6% were at the G0/G1 phase, 14.8 &#177; 3.1% were at the S phase and 54.1 &#177; 4.4% were at the G2/M phase. Experiments were repeated 3 times and the data are expressed as mean &#177; SEM.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>5873</offset><text>Behaviour before Activation of Donor Cell Nuclei</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>5922</offset><text>When confluent cells were transferred into M I oocytes, the fusion rate (60.2%) was significantly (P &lt; 0.05) higher than that (25.8%) of embryos reconstituted with nocodazole-treated cells and M I oocytes (Table 1). At 15 h after fusion, spots of condensed chromatin (Figure 1A and 1B) were observed in the majority (85.0%) of embryos reconstructed by transferring confluent cells and this percentage was significantly (P &lt; 0.05) higher than that (63.3%) of embryos reconstituted with nocodazole-treated cells. When nocodazole-treated cells were transferred into M I oocytes, one spot of condensed chromatin and one polar body (Figure 1C) was observed in 13.3% of reconstructed embryos. Regardless of the cell cycle of the donor cells, the percentage (3.3-5.0%) of embryos with swollen nuclei (Figure 1D and 1E) was low.</text></passage><passage><infon key="file">1471-213X-1-12-1.jpg</infon><infon key="id">F1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>6743</offset><text>Nuclear swelling and polar body formation in porcine reconstructed embryos. Embryos containing one (A) or two (B) spots of condensed chromatin, one spot of condensed chromatin and one polar body (C), one (D) or two (E) swollen nuclei or one swollen nucleus and one polar body (F). Embryos were reconstructed by transferring confluent (A and D) or nocodazole-treated (B, C, E and F) cells into enucleated M I oocytes. Bar 100 &#956;m.</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>7173</offset><text>Nuclear swelling and polar body formation at 15 h after fusion in porcine embryos reconstructed by transferring confluent (CON) or nocodazole-treated (NOC) cells into enucleated M I oocytes</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center" colspan="8"&gt;No. of embryos with&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td colspan="8"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center" colspan="4"&gt;Condensed chromatin&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td colspan="4"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center" colspan="2"&gt;No. of&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;No&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;One &amp;amp;&lt;/td&gt;&lt;td/&gt;&lt;td align="center" colspan="3"&gt;Swollen nucleus&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center" colspan="2"/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"/&gt;&lt;td/&gt;&lt;td align="center" colspan="3"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;No. of&lt;/td&gt;&lt;td align="center" colspan="2"&gt;complexes&lt;/td&gt;&lt;td align="center" colspan="2"&gt;No. of embryos&lt;/td&gt;&lt;td align="center"&gt;chromatin&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;polar&lt;/td&gt;&lt;td align="center"&gt;Total&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;Total&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"/&gt;&lt;td align="center" colspan="2"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;td align="center" colspan="2"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;td align="center"/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"/&gt;&lt;td align="center"/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Donor&lt;/td&gt;&lt;td align="center"&gt;trials&lt;/td&gt;&lt;td align="center"&gt;Treated&lt;/td&gt;&lt;td align="center"&gt;Fused (%)&lt;sup&gt;a&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;Examined&lt;/td&gt;&lt;td align="center"&gt;Surviving&lt;/td&gt;&lt;td align="center"&gt;/nucleus&lt;/td&gt;&lt;td align="center"&gt;One&lt;/td&gt;&lt;td align="center"&gt;Two&lt;/td&gt;&lt;td align="center"&gt;body (%)&lt;sup&gt;b&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;(%)&lt;sup&gt;b&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;One&lt;/td&gt;&lt;td align="center"&gt;Two&lt;/td&gt;&lt;td align="center"&gt;(%)&lt;sup&gt;b&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;CON&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td align="center"&gt;128&lt;/td&gt;&lt;td align="center"&gt;77 (60.2)&lt;sup&gt;c&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;40&lt;/td&gt;&lt;td align="center"&gt;40&lt;/td&gt;&lt;td align="center"&gt;4&lt;/td&gt;&lt;td align="center"&gt;34&lt;/td&gt;&lt;td align="center"&gt;0&lt;/td&gt;&lt;td align="center"&gt;0(0)&lt;/td&gt;&lt;td align="center"&gt;34 (85.0)&lt;sup&gt;c&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;2&lt;/td&gt;&lt;td align="center"&gt;0&lt;/td&gt;&lt;td align="center"&gt;2 (5.0)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;NOC&lt;/td&gt;&lt;td align="center"&gt;4&lt;/td&gt;&lt;td align="center"&gt;248&lt;/td&gt;&lt;td align="center"&gt;64 (25.8)&lt;sup&gt;d&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;32&lt;/td&gt;&lt;td align="center"&gt;30&lt;/td&gt;&lt;td align="center"&gt;10&lt;/td&gt;&lt;td align="center"&gt;9&lt;/td&gt;&lt;td align="center"&gt;6&lt;/td&gt;&lt;td align="center"&gt;4(13.3)&lt;/td&gt;&lt;td align="center"&gt;19 (63.3)&lt;sup&gt;d&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;0&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;1 (3.3)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>7363</offset><text>						No. of embryos with	 								 								Condensed chromatin				 												 			No. of			No			One &amp;		Swollen nucleus	 												 		No. of	complexes	No. of embryos	chromatin			polar	Total			Total	 													 	Donor	trials	Treated	Fused (%)a	Examined	Surviving	/nucleus	One	Two	body (%)b	(%)b	One	Two	(%)b	 	CON	3	128	77 (60.2)c	40	40	4	34	0	0(0)	34 (85.0)c	2	0	2 (5.0)	 	NOC	4	248	64 (25.8)d	32	30	10	9	6	4(13.3)	19 (63.3)d	0	1	1 (3.3)	 	</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>7810</offset><text>aPercentage of complexes treated. bPercentage of embryos surviving. c-dValues with different superscripts are significantly different (P &lt; 0.05).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>7956</offset><text>Behaviour after Activation of Donor Cell Nuclei</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8004</offset><text>As shown in Table 2, when confluent cells were used as donors, the fusion rate (60.2-62.7%) was significantly (P &lt; 0.05) higher than that (29.0-33.6%) of nocodazole-treated cells regardless of the maturation stage of the recipient oocytes. At 6 h after activation, swollen nuclei were observed in 50.0 and 88.9% of embryos produced by transferring confluent cells into M I or M II oocytes with no significant differences. Although 34.4-39.5% of embryos reconstituted with nocodazole-treated cells had swollen nuclei, the percentage of embryos with both the swollen nucleus and polar body (Figure 1F) was only 6.3-10.5%.</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>8624</offset><text>Nuclear swelling and polar body formation at 6 h after activation in porcine embryos reconstructed by transferring confluent (CON) or nocodazole-treated (NOC) cells into enucleated M I or M II oocytesa</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center" colspan="9"&gt;No. of embryos with&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td colspan="9"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center" colspan="4"&gt;Swollen nucleus&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td colspan="4"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center" colspan="4"&gt;Condensed chromatin&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;One &amp;amp;&lt;/td&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td colspan="4"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center" colspan="2"&gt;No. of complexes&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;No&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;One &amp;amp;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;polar&lt;/td&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center" colspan="2"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Reci-&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;Fused&lt;/td&gt;&lt;td align="center" colspan="2"&gt;No. of embryos&lt;/td&gt;&lt;td align="center"&gt;chromatin&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;polar&lt;/td&gt;&lt;td align="center"&gt;Total&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;body&lt;/td&gt;&lt;td align="center"&gt;Total&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"/&gt;&lt;td align="center" colspan="2"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;td align="center"/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"/&gt;&lt;td align="center"/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"/&gt;&lt;td align="center"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;pient&lt;/td&gt;&lt;td align="center"&gt;Donor&lt;/td&gt;&lt;td align="center"&gt;Treated&lt;/td&gt;&lt;td align="center"&gt;(%)&lt;sup&gt;b&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;Examined&lt;/td&gt;&lt;td align="center"&gt;Surviving&lt;/td&gt;&lt;td align="center"&gt;/nucleus&lt;/td&gt;&lt;td align="center"&gt;One&lt;/td&gt;&lt;td align="center"&gt;Two&lt;/td&gt;&lt;td align="center"&gt;body&lt;/td&gt;&lt;td align="center"&gt;(%)&lt;sup&gt;c&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;One&lt;/td&gt;&lt;td align="center"&gt;Two&lt;/td&gt;&lt;td align="center"&gt;(%)&lt;sup&gt;c&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;(%)&lt;sup&gt;c&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;M I&lt;/td&gt;&lt;td align="center"&gt;CON&lt;/td&gt;&lt;td align="center"&gt;128&lt;/td&gt;&lt;td align="center"&gt;77 (60.2)&lt;sup&gt;d&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;37&lt;/td&gt;&lt;td align="center"&gt;36&lt;/td&gt;&lt;td align="center"&gt;5&lt;/td&gt;&lt;td align="center"&gt;12&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;0&lt;/td&gt;&lt;td align="center"&gt;13(36.1)&lt;/td&gt;&lt;td align="center"&gt;18&lt;/td&gt;&lt;td align="center"&gt;0&lt;/td&gt;&lt;td align="center"&gt;0(0)&lt;/td&gt;&lt;td align="center"&gt;18 (50.0)&lt;sup&gt;de&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;NOC&lt;/td&gt;&lt;td align="center"&gt;200&lt;/td&gt;&lt;td align="center"&gt;58 (29.0)&lt;sup&gt;e&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;32&lt;/td&gt;&lt;td align="center"&gt;32&lt;/td&gt;&lt;td align="center"&gt;11&lt;/td&gt;&lt;td align="center"&gt;7&lt;/td&gt;&lt;td align="center"&gt;2&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;10(31.3)&lt;/td&gt;&lt;td align="center"&gt;9&lt;/td&gt;&lt;td align="center"&gt;0&lt;/td&gt;&lt;td align="center"&gt;2 (6.3)&lt;/td&gt;&lt;td align="center"&gt;11(34.4)&lt;sup&gt;d&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;M II&lt;/td&gt;&lt;td align="center"&gt;CON&lt;/td&gt;&lt;td align="center"&gt;75&lt;/td&gt;&lt;td align="center"&gt;47 (62.7)&lt;sup&gt;d&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;47&lt;/td&gt;&lt;td align="center"&gt;45&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;4&lt;/td&gt;&lt;td align="center"&gt;0&lt;/td&gt;&lt;td align="center"&gt;0&lt;/td&gt;&lt;td align="center"&gt;4 (8.9)&lt;/td&gt;&lt;td align="center"&gt;38&lt;/td&gt;&lt;td align="center"&gt;2&lt;/td&gt;&lt;td align="center"&gt;0(0)&lt;/td&gt;&lt;td align="center"&gt;40 (88.9)&lt;sup&gt;e&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;NOC&lt;/td&gt;&lt;td align="center"&gt;122&lt;/td&gt;&lt;td align="center"&gt;41 (33.6)&lt;sup&gt;e&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;41&lt;/td&gt;&lt;td align="center"&gt;38&lt;/td&gt;&lt;td align="center"&gt;9&lt;/td&gt;&lt;td align="center"&gt;7&lt;/td&gt;&lt;td align="center"&gt;5&lt;/td&gt;&lt;td align="center"&gt;2&lt;/td&gt;&lt;td align="center"&gt;14 (36.8)&lt;/td&gt;&lt;td align="center"&gt;7&lt;/td&gt;&lt;td align="center"&gt;4&lt;/td&gt;&lt;td align="center"&gt;4(10.5)&lt;/td&gt;&lt;td align="center"&gt;15 (39.5)&lt;sup&gt;de&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>8826</offset><text>						No. of embryos with	 								 												Swollen nucleus	 													 								Condensed chromatin			One &amp;		 													 			No. of complexes			No			One &amp;				polar		 															 	Reci-			Fused	No. of embryos	chromatin			polar	Total			body	Total	 															 	pient	Donor	Treated	(%)b	Examined	Surviving	/nucleus	One	Two	body	(%)c	One	Two	(%)c	(%)c	 	M I	CON	128	77 (60.2)d	37	36	5	12	1	0	13(36.1)	18	0	0(0)	18 (50.0)de	 		NOC	200	58 (29.0)e	32	32	11	7	2	1	10(31.3)	9	0	2 (6.3)	11(34.4)d	 	M II	CON	75	47 (62.7)d	47	45	1	4	0	0	4 (8.9)	38	2	0(0)	40 (88.9)e	 		NOC	122	41 (33.6)e	41	38	9	7	5	2	14 (36.8)	7	4	4(10.5)	15 (39.5)de	 	</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>9471</offset><text>aExperiments were repeated 3 times. bPercentage of complexes treated. cPercentage of embryos surviving. d-eValues with different superscripts are significantly different (P &lt; 0.05).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>9653</offset><text>Development of Reconstructed Embryos</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9690</offset><text>The cleavage rate (38.2%) of embryos reconstituted with confluent cells and M II oocytes was significantly (P &lt; 0.05) higher than that (5.3-9.7%) of embryos produced by transferring confluent or nocodazole-treated cells into M I oocytes (Table 3). However, this percentage (38.2%) did not significantly differ from that of embryos reconstituted with nocodazole-treated cells and M II oocytes (15.4%). When embryos reconstituted with confluent cells and M I oocytes were cultured, 2 (1.5%) blastocysts (Figure 2) were obtained and this percentage was significantly (P &lt; 0.05) lower than that of embryos produced by transferring confluent cells into M II oocytes (7.6%). There were no significant differences in mean numbers of cells in the blastocysts between different maturation stages of the recipient oocytes. No embryos developed to the blastocyst stage when nocodazole-treated cells were used as donors regardless of the maturation stage of the recipient oocytes.</text></passage><passage><infon key="file">1471-213X-1-12-2.jpg</infon><infon key="id">F2</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>10659</offset><text>A porcine blastocyst developed from embryos reconstituted with confluent adult somatic cells and enucleated M I oocytes matured in a protein-free medium. Bar 100 &#956;m.</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>10826</offset><text>Development of porcine embryos reconstructed by transferring confluent (CON) or nocodazole-treated (NOC) cells into enucleated M I or M II oocytes</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;No. of&lt;/td&gt;&lt;td align="center"&gt;No. of&lt;/td&gt;&lt;td align="center" colspan="2"&gt;No. (%)&lt;sup&gt;b&lt;/sup&gt; of embryos developed to&lt;/td&gt;&lt;td align="center"&gt;Mean no. &#177; SEM&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"/&gt;&lt;td align="center"/&gt;&lt;td align="center" colspan="2"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;td align="center"&gt;Mean no. &#177; SEM&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;No. of&lt;/td&gt;&lt;td align="center"&gt;complexes&lt;/td&gt;&lt;td align="center"&gt;complexes&lt;/td&gt;&lt;td align="center"&gt;&#8805; 2-cell&lt;/td&gt;&lt;td align="center"&gt;Blastocyst&lt;/td&gt;&lt;td align="center"&gt;of cells in&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Recipient&lt;/td&gt;&lt;td align="center"&gt;Donor&lt;/td&gt;&lt;td align="center"&gt;trials&lt;/td&gt;&lt;td align="center"&gt;treated&lt;/td&gt;&lt;td align="center"&gt;fused (%)&lt;sup&gt;a&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;(2)&lt;sup&gt;c&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;(7)&lt;sup&gt;c&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;blastocysts&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;M I&lt;/td&gt;&lt;td align="center"&gt;CON&lt;/td&gt;&lt;td align="center"&gt;4&lt;/td&gt;&lt;td align="center"&gt;180&lt;/td&gt;&lt;td align="center"&gt;132 (73.3)&lt;sup&gt;d&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;7 (5.3)&lt;sup&gt;d&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;2(1.5)&lt;sup&gt;d&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;19.0 &#177; 5.0&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;NOC&lt;/td&gt;&lt;td align="center"&gt;4&lt;/td&gt;&lt;td align="center"&gt;179&lt;/td&gt;&lt;td align="center"&gt;72 (40.2)&lt;sup&gt;de&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;7 (9.7)&lt;sup&gt;d&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;0(0)&lt;sup&gt;d&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;-&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;M II&lt;/td&gt;&lt;td align="center"&gt;CON&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td align="center"&gt;227&lt;/td&gt;&lt;td align="center"&gt;131 (57.7)&lt;sup&gt;d&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;50 (38.2)&lt;sup&gt;e&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;10 (7.6)&lt;sup&gt;e&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;45.1 &#177; 6.2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;NOC&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td align="center"&gt;136&lt;/td&gt;&lt;td align="center"&gt;39 (28.7)&lt;sup&gt;e&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;6 (15.4)&lt;sup&gt;de&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;0(0)&lt;sup&gt;d&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;-&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>10973</offset><text>			No. of	No. of	No. (%)b of embryos developed to	Mean no. &#177; SEM	 							Mean no. &#177; SEM	 			No. of	complexes	complexes	&#8805; 2-cell	Blastocyst	of cells in	 	Recipient	Donor	trials	treated	fused (%)a	(2)c	(7)c	blastocysts	 	M I	CON	4	180	132 (73.3)d	7 (5.3)d	2(1.5)d	19.0 &#177; 5.0	 		NOC	4	179	72 (40.2)de	7 (9.7)d	0(0)d	-	 	M II	CON	3	227	131 (57.7)d	50 (38.2)e	10 (7.6)e	45.1 &#177; 6.2	 		NOC	3	136	39 (28.7)e	6 (15.4)de	0(0)d	-	 	</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>11401</offset><text>aPercentage of complexes treated. bPercentage of embryos cultured. cNumbers in parentheses indicate the time of examination (days after culture). d-eValues with different superscripts within each column are significantly different (P &lt; 0.05).</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>11644</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>11655</offset><text>The results of the present study demonstrated the in vitro developmental ability to blastocysts of porcine embryos reconstituted with somatic cells and enucleated M I oocytes. To our knowledge, this is the first report that describes blastocyst formation of embryos reconstituted with M I oocytes in mammals.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>11964</offset><text>When donor nuclei are transferred into non-treated M II recipient oocytes that have high MPF activity, various changes referred to as nuclear remodeling occur in the introduced nuclei. This phenomenon is considered to involve nuclear structural changes, such as nuclear envelope breakdown, premature chromosome condensation and pronuclear development and swelling. Nuclear remodeling is thought to be a result of the exchange of proteins between the nuclear and cytoplasmic compartments and is pre-requisite to or is part of the reprogramming of gene expression. Therefore, it is generally considered that the phenomenon of nuclear swelling is one essential component of the more complex process of genetic reprogramming. In the present study, when confluent or nocodazole-treated cells were transferred into enucleated M I oocytes, nuclear swelling was observed in 34.4-50.0% of reconstructed embryos after activation. This result suggests that porcine M I oocytes can initiate reprogramming of both confluent and nocodazole-treated cells. Moreover, some reconstructed embryos produced by transferring confluent cells developed to the blastocyst stage. Because activation of the embryonic genome occurs by the 4-cell stage in the pig, it is evident that donor nuclei were at least partially reprogrammed in these blastocysts. Therefore, our results clearly indicate that porcine M I oocytes like M II oocytes have the ability to reprogram confluent somatic cell nuclei as determined by nuclear remodeling and in vitro development.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>13496</offset><text>The blastocyst formation rate of reconstructed embryos produced by transferring confluent cells into M I oocytes was significantly lower than that of embryos reconstituted with confluent cells and M II oocytes although there were no significant differences in percentages of embryos with swollen nuclei between different maturation stages of recipient oocytes. These results suggest that the reprogramming of donor nuclei may be started but is not completed in some embryos reconstituted with M I oocytes. It has been suggested that nuclear swelling may not necessarily be a sufficient indicator of developmental potential in a reconstructed embryo. In addition to MPF, mitogen-activated protein (MAP) kinase is also known as an important protein kinase that regulates the meiotic cell cycle. In mouse oocytes, MAP kinase plays a more important role in controlling chromatin and microtubule behavior than MPF. However, MAP kinase and MPF activities do not vary between M I and M II of porcine oocytes because phosphorylations of MAP kinase and histone H1 kinase which corresponds to MPF activity reach the peak level at M I and remain high beyond M II. Potentially, an unknown factor(s) is required for reprogramming of nuclei, which is present in M II oocytes but may not be present or active in M I oocytes. It is known that pronuclear exchange between zygotes does not prevent development of the reconstructed embryos but transfer of donor nuclei from later developmental stages into enucleated zygotes brings about restricted development. One explanation of this phenomenon is that a factor(s) required for reprogramming of donor nuclei is removed with the pronuclei from recipient zygotes. Similarly, the factor(s) would be present near the chromosomes at M I and removed with the M I plate during enucleation in many oocytes. In contrast, the factor(s) is believed to be in cytoplasts derived from M II oocytes because embryos reconstituted with donor nuclei from later developmental stages and enucleated M II oocytes can develop to adults. An alternative cause is the effect of cytochalasin B, a microfilament polymerization inhibitor. In the present study, reconstructed embryos produced by transferring confluent cells into M I oocytes were cultured in the maturation medium supplemented with cytochalasin B to prevent loss of chromosomes by polar body formation. However, it has been reported recently that morphologically normal M I spindles are formed but further meiotic progression does not occur in porcine oocytes matured in a cytochalasin B-containing medium. Therefore, it is possible that reprogramming of nuclei transferred into M I oocytes is inhibited by cytochalasin B. Thirdly, M I and M II oocytes may differ in cytoplasmic competence. When porcine M I oocytes are inseminated with spermatozoa in vitro, the formation rate of male and female pronuclei is significantly lower than that in M II oocytes. Finally, optimal conditions for activation may vary between M I and M II oocytes. To our knowledge, there are no reports that describe activation of MI oocytes in mammals. Parameters of the activation pulse used in the present study were also optimized in a preliminary experiment using M II oocytes. It is possible that optimization of methods for activation improves the development of embryos reconstituted with M I oocytes.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>16852</offset><text>In contrast, no reconstructed embryos developed to the blastocyst stage regardless of the maturation stage of the recipient oocytes when nocodazole-treated cells were transferred, although nuclear swelling was observed in 34.4-39.5% of the embryos. When cells in M phase are used as donors, reconstructed embryos with a polar body are diploid but embryos without a polar body are tetraploid. In the present study, the percentage of embryos with both a swollen nucleus and a polar body was low after transfer of nocodazole-treated cells. In the bovine, the potential of reconstructed embryos with or without the polar body to develop to the blastocyst stage is not different. However, this study suggests that porcine tetraploid embryos may not develop to blastocysts.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>17620</offset><text>In the present study, there was a significant difference in fusion rates between the cell cycles of donor cells. The plasma membrane of nocodazole-treated cells was weak compared to that of confluent cells and many cells were broken before and after applying a fusion pulse. Parameters of the fusion pulse were optimized in a preliminary experiment using confluent cells. Therefore, it is expected that optimal conditions for fusion vary among cell cycles of donor cells in the pig.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>18103</offset><text>In general, in vitro maturation (IVM) media used to prepare recipient oocytes for production of cloned embryos are usually supplemented with fetal calf serum (FCS) or porcine follicular fluid (pFF). It is a well known fact that growth factors and hormones, in addition to many other factors, are abundant in serum and follicular fluid. Therefore, supplementation of IVM media with FCS or pFF presents the potential problems in proper quality control and repeatability among laboratories or replicates. Recently, a defined IVM system for porcine oocytes was developed in order to eliminate such variability. In the present study, 7.6% of reconstructed embryos produced by transferring confluent adult somatic cells into enucleated M II oocytes matured in the protein-free medium developed to the blastocyst stage. The blastocyst formation rate in our study is similar to results from the recent reports in which porcine adult somatic (cumulus) cells (5-10%) or fetal fibroblasts (1-16%) were transferred into enucleated M II oocytes matured in media supplemented with pFF. In addition, quality of the blastocysts based on the mean number of cells (45.1 cells) equals if not exceeds results from previous studies (cumulus cells: 28.9 cells; fetal fibroblasts: 12.5-66.0 cells). Although this study did not compare defined IVM medium with complex medium the results indicate that protein-free IVM medium is suitable for maturing recipient oocytes for the production of cloned embryos. The defined conditions will allow us to examine factors affecting nuclear reprogramming of reconstructed embryos more precisely and better understand the basic molecular mechanisms of the process.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>19782</offset><text>Remarkable conclusions</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>19794</offset><text>Our research has revealed that porcine M I oocytes have the potential to become blastocysts after nuclear transfer of somatic cells. However, the process of nuclear reprogramming may vary between M II and M III based on the developmental abilities of retrieved embryos, which differ from the maturation stages of recipient ovations. Comparing these occurrences would provide valuable information about the mechanisms of nucleosynthesis in cloned embryols. We recommend using defined IVM medium to conduct experiments.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>20563</offset><text>Materials and Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>20585</offset><text>Donor Cells</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>20597</offset><text>Porcine fibroblasts were harvested from an ear skin biopsy obtained from an adult pig. The tissue was finely minced and digested in 0.125% (w/v) trypsin/0.02% (w/v) EDTA solution (Sigma Chemical Co., St. Louis, MO) containing 1 mg/ml collagenase (Sigma) and 0.3 mg/ml hyaluronidase (Sigma) for 2 h at 37&#176;C. After digestion, the mixture was filtered through four layers of sterile gauze and cells were pelleted by centrifugation. Cells were cultured in DMEM/F-12 medium (Sigma) supplemented with 20% (v/v) FCS (Biowhittaker Inc., Walkersville, MD) under 5% CO2 in air at 37&#176;C. After reaching confluence, cells were passaged. Passage 2 fibroblasts were trypsinized, suspended in the culture medium with 10% (v/v) dimethyl sulfoxide (Sigma) and stored as frozen aliquots. Donor cells were used for nuclear transfer between passages 3 and 9 of culture. For preparation of donors in G0/G1 phase, the cells were allowed to grow to confluency by culturing for 6 days and a single cell suspension was prepared by standard trypsinization. The cells were used for nuclear transfer within 5 days after reaching confluence. After 2-4 days of subculturing, the cells (approximately 50% of confluency) were cultured in the medium supplemented with 0.3 &#956;g/ml nocodazole (Sigma), a microtubule polymerization inhibitor, for 10 h to induce G2/M phase arrest. After gentle pipetting, cells floating in the medium were collected. Both donor cells were prepared immediately prior to nuclear transfer.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>22081</offset><text>Recipient Oocytes</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>22099</offset><text>Ovaries were collected from a local slaughterhouse and transported in 0.9% saline at approximately 32&#176;C. Follicles greater than 3 mm in diameter were aspirated with an 18-gauge needle using vacuum suction (100 mmHg; 28 ml/min). Aspirated oocytes that had an evenly granulated cytoplasm and were surrounded by at least two uniform layers of compact cumulus cells were selected and washed three times in Hepes-buffered synthetic oviductal fluid medium. Oocytes were transferred into tubes containing Hepes-buffered TCM-199 (Gibco BRL, Grand Island, NY) supplemented with 0.57 mM cysteine, 10 ng/ml epidermal growth factor (Sigma), 100 IU/ml penicillin, 100 &#956;g/ml streptomycin, 0.25 ng/ml amphotericin, 0.01 IU/ml porcine FSH (Sioux Biochemicals, Sioux Center, IA), 0.01 IU/ml porcine LH (Sioux Biochemicals) and 0.1% (w:v) polyvinyl alcohol (maturation medium), and shipped to the laboratory overnight (20-24 h) at 38.5&#176;C. Oocytes continued to be cultured in the tubes under 38.5&#176;C until enucleation.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>23102</offset><text>Nuclear Transfer</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>23119</offset><text>Reconstructed embryos were produced using a modification of the method described by Miyoshi et al.. Cumulus cells were removed by vortexing with 0.1% (w:v) hyaluronidase and denuded oocytes were transferred into 100 &#956;l of Hepes-buffered TCM-199 supplemented with 7.5 &#956;g/ml cytochalasin B (Sigma) and 10% FCS with the osmolarity adjusted to 300 mOsm by adding sorbitol (manipulation medium) at 29 or 42 h after IVM. The M I plate or the first polar body and M II plate were removed by aspiration with a 15-&#956;m inner diameter glass pipette. The oocytes had been previously stained in the manipulation medium supplemented with 5 &#956;g/ml Hoechst 33342 (Sigma) for 20 min and confirmation of successful enucleation was achieved by visualizing the cytoplast and removed cytoplasm under ultraviolet light. After enucleation, a donor cell was inserted into the perivitelline space of each enucleated oocyte using the same glass pipette. When nocodazole-treated cells were used as donors, large cells (cell diameter was &gt;15 &#956;m) were selected. In our preliminary experiment, such a relatively large cytoplasmic volume was typical of cells at the G2/M phase as described by Wakayama et al.. Cell-oocyte complexes were washed in TCM-199 supplemented with 10% FCS, transferred to the same medium and kept under 5% CO2 in air at 38.5&#176;C until fusion.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>24458</offset><text>Fusion was performed in a 100 mm dish filled with 15 ml of Zimmermann fusion medium. Two stainless steel wires (100 &#956;m diameter) attached to micromanipulators were used as electrodes. The single cell-oocyte complex was sandwiched between the electrodes and oriented with the contact surface between the cytoplast and the donor cell perpendicular to the electrodes. The distance between the electrodes was about 100 &#956;m. Membrane fusion was induced by applying a single direct current pulse of 250 V/mm for a duration of 20 &#956;sec with a prepulse of alternating current field of 5 V, 1 MHz for 2 sec using an LF 101 Fusion Machine (TR Tech Co., Tokyo, Japan). Following fusion, the complexes were washed in G 1.2 medium and cultured for a period of 1 h in 100 &#956;l of the same medium. Fusion rate was then determined by microscopic examination.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>25301</offset><text>Activation of Reconstructed Embryos</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>25337</offset><text>Fused embryos were washed once in Zimmermann fusion medium and then placed between 2 wire electrodes (1 mm apart) of the fusion chamber slide with 15 ml of the fusion medium. Direct current pulses of 75 V/mm were applied twice to the embryos for a duration of 60 &#956;sec at intervals of 5 sec.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>25629</offset><text>Examination of Reconstructed Embryos</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>25666</offset><text>Before and after activation, fused embryos were stained with 5 &#956;g/ml Hoechst 33342 for 20 min and then examined for nuclear swelling and polar body formation under ultraviolet light. The nucleus with a diameter that was at least twice bigger than the original size of donor cell nuclei was considered to be a swollen nucleus.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>25993</offset><text>Experimental Studies</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_3</infon><offset>26014</offset><text>Cell Cycle Analysis of Donor Cells</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>26049</offset><text>In Experiment 1, the cell cycle stages of confluent and nocodazole-treated donor cells were analyzed using flow cytometry. Collected cells (approx. 2 &#215; 106 cells) were centrifuged and the pellet was re-suspended in 1 ml of cold PBS. Then, cells were fixed by adding 4 ml of -20&#176;C absolute ethanol and stored in -20&#176;C. Before analysis, cells were centrifuged and the pellet was re-suspended in 1 ml of PBS. Then, 100 &#956;l of DNase-free RNase A (200 &#956;g/ml; Sigma) was added and samples were incubated for 30 min at 37&#176;C. After incubation, 100 &#956;l of propidium iodide (1 mg/ml; Sigma) was added into each sample and cells were analyzed using FACStartPLUS analyzer (Becton Dickinson, San Jose, CA).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_3</infon><offset>26748</offset><text>Behavior before Activation of Donor Cell Nuclei</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>26796</offset><text>In Experiment 2, we examined the behavior before activation of donor cell nuclei transferred into enucleated M I oocytes. M I oocytes were enucleated at 29 h after IVM and confluent or nocodazole-treated cells were transferred. Fused embryos were cultured in the maturation medium for 15 h and then examined for nuclear swelling and polar body formation. When confluent cells were used as donors, fused embryos were cultured in the medium supplemented with 7.5 &#956;g/ml cytochalasin B to prevent extrusion of polar bodies.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_3</infon><offset>27317</offset><text>Behavior after Activation of Donor Cell Nuclei</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>27364</offset><text>In Experiment 3, the behavior of nuclei of confluent or nocodazole-treated cells transferred into enucleated M I or M II oocytes was examined after activation. Embryos reconstituted with M I oocytes were cultured in the maturation medium with or without cytochalasin B for 15 h and then activated. M II oocytes were enucleated at 42 h after IVM and embryos reconstituted with them were activated at 3 h after fusion. Activated embryos were cultured in 100 &#956;l of G 1.2 medium for 6 h and then examined for nuclear swelling and polar body formation. When confluent cells were used as donors, embryos were cultured in G1.2 medium supplemented with 7.5 &#956;g/ml cytochalasin B for 2 h after activation to prevent extrusion of polar bodies.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_3</infon><offset>28099</offset><text>Development of Reconstructed Embryos</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>28136</offset><text>Experiment 4 was undertaken to compare in vitro developmental abilities of reconstructed embryos produced by transferring confluent or nocodazole-treated cells into enucleated M I or M II oocytes as described above. After culture in G1.2 medium for 3 days, the embryos were transferred into 100 &#956;l of G2.2 medium and continued to be cultured. The embryos were examined for cleavage and blastocyst formation at 2 and 7 days after culture, respectively. At the end of the culture period, the number of cells in blastocysts was examined. The blastocysts were placed on slides with a drop of mounting medium consisting of glycerol and PBS (9:1) containing 0.1 mg/ml Hoechst 33342. A cover slip was placed on the top of the blastocysts and the edge was sealed with fingernail polish. The numbers of nuclei were counted under ultraviolet light.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>28976</offset><text>Statistical Analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>28997</offset><text>All percentage data were subjected to an arcsin square root transformation in each replicate and the transformed values were analyzed using one-way (Experiment 2) or two-way (Experiments 3 and 4) ANOVA followed by Student-Newman-Keuls test. The numbers of cells in blastocysts were analyzed using Student t-test. A probability of P &lt; 0.05 was considered statistically significant.</text></passage><passage><infon key="fpage">64</infon><infon key="lpage">66</infon><infon key="name_0">surname:Campbell;given-names:KHS</infon><infon key="name_1">surname:McWhir;given-names:J</infon><infon key="name_2">surname:Ritchie;given-names:WA</infon><infon key="name_3">surname:Wilmut;given-names:I</infon><infon key="pub-id_doi">10.1038/380064a0</infon><infon key="pub-id_pmid">8598906</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">380</infon><infon key="year">1996</infon><offset>29378</offset><text>Sheep cloned by nuclear transfer from a cultured cell line</text></passage><passage><infon key="fpage">810</infon><infon key="lpage">813</infon><infon key="name_0">surname:Wilmut;given-names:I</infon><infon key="name_1">surname:Schnieke;given-names:AE</infon><infon key="name_2">surname:McWhir;given-names:J</infon><infon key="name_3">surname:Kind;given-names:AJ</infon><infon key="name_4">surname:Campbell;given-names:KHS</infon><infon key="pub-id_doi">10.1038/385810a0</infon><infon key="pub-id_pmid">9039911</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">385</infon><infon key="year">1997</infon><offset>29437</offset><text>Viable offspring derived from fetal and adult mammalian cells</text></passage><passage><infon key="fpage">1256</infon><infon key="lpage">1258</infon><infon key="name_0">surname:Cibelli;given-names:JB</infon><infon key="name_1">surname:Stice;given-names:SL</infon><infon key="name_2">surname:Golueke;given-names:PJ</infon><infon key="name_3">surname:Kane;given-names:JJ</infon><infon key="name_4">surname:Jerry;given-names:J</infon><infon key="name_5">surname:Blackwell;given-names:C</infon><infon key="name_6">surname:Abel Ponce de;given-names:Leon</infon><infon key="name_7">surname:Robl;given-names:JM</infon><infon key="pub-id_doi">10.1126/science.280.5367.1256</infon><infon key="pub-id_pmid">9596577</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">280</infon><infon key="year">1998</infon><offset>29499</offset><text>Cloned transgenic calves produced from nonquiescent fetal fibroblasts</text></passage><passage><infon key="fpage">2095</infon><infon key="lpage">2098</infon><infon key="name_0">surname:Kato;given-names:Y</infon><infon key="name_1">surname:Tani;given-names:T</infon><infon key="name_2">surname:Sotomaru;given-names:Y</infon><infon key="name_3">surname:Kurokawa;given-names:K</infon><infon key="name_4">surname:Kato;given-names:J</infon><infon key="name_5">surname:Doguchi;given-names:H</infon><infon key="name_6">surname:Yasue;given-names:H</infon><infon key="name_7">surname:Tsunoda;given-names:Y</infon><infon key="pub-id_doi">10.1126/science.282.5396.2095</infon><infon key="pub-id_pmid">9851933</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">282</infon><infon key="year">1998</infon><offset>29569</offset><text>Eight calves cloned from somatic cells of a single adult</text></passage><passage><infon key="fpage">996</infon><infon key="lpage">1005</infon><infon key="name_0">surname:Wells;given-names:DN</infon><infon key="name_1">surname:Misica;given-names:PM</infon><infon key="name_2">surname:Tervit;given-names:HR</infon><infon key="pub-id_pmid">10084977</infon><infon key="section_type">REF</infon><infon key="source">Biol Reprod</infon><infon key="type">ref</infon><infon key="volume">60</infon><infon key="year">1999</infon><offset>29626</offset><text>Production of cloned calves following nuclear transfer with cultured adult mural granulosa cells</text></passage><passage><infon key="fpage">369</infon><infon key="lpage">374</infon><infon key="name_0">surname:Wakayama;given-names:T</infon><infon key="name_1">surname:Perry;given-names:ACF</infon><infon key="name_2">surname:Zuccotti;given-names:M</infon><infon key="name_3">surname:Johnson;given-names:KR</infon><infon key="name_4">surname:Yanagimachi;given-names:R</infon><infon key="pub-id_doi">10.1038/28615</infon><infon key="pub-id_pmid">9690471</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">394</infon><infon key="year">1998</infon><offset>29723</offset><text>Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei</text></passage><passage><infon key="fpage">127</infon><infon key="lpage">128</infon><infon key="name_0">surname:Wakayama;given-names:T</infon><infon key="name_1">surname:Yanagimachi;given-names:R</infon><infon key="pub-id_doi">10.1038/9632</infon><infon key="pub-id_pmid">10369248</infon><infon key="section_type">REF</infon><infon key="source">Nature genet</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">1999</infon><offset>29811</offset><text>Cloning of male mice from adult tail-tip cells</text></passage><passage><infon key="fpage">456</infon><infon key="lpage">461</infon><infon key="name_0">surname:Baguisi;given-names:A</infon><infon key="name_1">surname:Behboodi;given-names:E</infon><infon key="name_10">surname:Palacios;given-names:MJ</infon><infon key="name_11">surname:Ayres;given-names:SL</infon><infon key="name_12">surname:Denniston;given-names:RS</infon><infon key="name_13">surname:Hayes;given-names:ML</infon><infon key="name_14">surname:Ziomek;given-names:CA</infon><infon key="name_15">surname:Meade;given-names:HM</infon><infon key="name_16">surname:Godke;given-names:RA</infon><infon key="name_17">surname:Gavin;given-names:WG</infon><infon key="name_18">surname:Overstrom;given-names:EW</infon><infon key="name_19">surname:Echelard;given-names:Y</infon><infon key="name_2">surname:Melican;given-names:DT</infon><infon key="name_3">surname:Pollock;given-names:JS</infon><infon key="name_4">surname:Destrempes;given-names:MM</infon><infon key="name_5">surname:Cammuso;given-names:C</infon><infon key="name_6">surname:Williams;given-names:JL</infon><infon key="name_7">surname:Nims;given-names:SD</infon><infon key="name_8">surname:Porter;given-names:CA</infon><infon key="name_9">surname:Midura;given-names:P</infon><infon key="pub-id_doi">10.1038/8632</infon><infon key="pub-id_pmid">10331804</infon><infon key="section_type">REF</infon><infon key="source">Nature Biotech</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">1999</infon><offset>29858</offset><text>Production of goats by somatic cell nuclear transfer</text></passage><passage><infon key="fpage">1188</infon><infon key="lpage">1190</infon><infon key="name_0">surname:Onishi;given-names:A</infon><infon key="name_1">surname:Iwamoto;given-names:M</infon><infon key="name_2">surname:Akita;given-names:T</infon><infon key="name_3">surname:Mikawa;given-names:S</infon><infon key="name_4">surname:Takeda;given-names:K</infon><infon key="name_5">surname:Awata;given-names:T</infon><infon key="name_6">surname:Hanada;given-names:H</infon><infon key="name_7">surname:Perry;given-names:ACF</infon><infon key="pub-id_doi">10.1126/science.289.5482.1188</infon><infon key="pub-id_pmid">10947985</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">289</infon><infon key="year">2000</infon><offset>29911</offset><text>Pig cloning by microinjection of fetal fibroblast nuclei</text></passage><passage><infon key="fpage">86</infon><infon key="lpage">90</infon><infon key="name_0">surname:Polejaeva;given-names:IA</infon><infon key="name_1">surname:Chen;given-names:SH</infon><infon key="name_10">surname:Colman;given-names:A</infon><infon key="name_11">surname:Campbell;given-names:KHS</infon><infon key="name_2">surname:Vaught;given-names:TD</infon><infon key="name_3">surname:Page;given-names:RL</infon><infon key="name_4">surname:Mullins;given-names:J</infon><infon key="name_5">surname:Ball;given-names:S</infon><infon key="name_6">surname:Dai;given-names:Y</infon><infon key="name_7">surname:Boone;given-names:J</infon><infon key="name_8">surname:Walker;given-names:S</infon><infon key="name_9">surname:Ayares;given-names:DL</infon><infon key="pub-id_doi">10.1038/35024082</infon><infon key="pub-id_pmid">10993078</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">407</infon><infon key="year">2000</infon><offset>29968</offset><text>Cloned pigs produced by nuclear transfer from adult somatic cells</text></passage><passage><infon key="fpage">1055</infon><infon key="lpage">1059</infon><infon key="name_0">surname:Betthauser;given-names:J</infon><infon key="name_1">surname:Forsberg;given-names:E</infon><infon key="name_10">surname:Lesmeister;given-names:T</infon><infon key="name_11">surname:Mallon;given-names:K</infon><infon key="name_12">surname:Mell;given-names:G</infon><infon key="name_13">surname:Misica;given-names:P</infon><infon key="name_14">surname:Pace;given-names:M</infon><infon key="name_15">surname:Pfister-Genskow;given-names:M</infon><infon key="name_16">surname:Strelchenko;given-names:N</infon><infon key="name_17">surname:Voelker;given-names:G</infon><infon key="name_18">surname:Watt;given-names:S</infon><infon key="name_19">surname:Thompson;given-names:S</infon><infon key="name_2">surname:Augenstein;given-names:M</infon><infon key="name_20">surname:Bishop;given-names:M</infon><infon key="name_3">surname:Childs;given-names:L</infon><infon key="name_4">surname:Eilertsen;given-names:K</infon><infon key="name_5">surname:Enos;given-names:J</infon><infon key="name_6">surname:Forsythe;given-names:T</infon><infon key="name_7">surname:Golueke;given-names:P</infon><infon key="name_8">surname:Jurgella;given-names:G</infon><infon key="name_9">surname:Koppang;given-names:R</infon><infon key="pub-id_doi">10.1038/80242</infon><infon key="pub-id_pmid">11017042</infon><infon key="section_type">REF</infon><infon key="source">Nature Biotech</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">2000</infon><offset>30034</offset><text>Production of cloned pigs from in vitro systems</text></passage><passage><infon key="fpage">40</infon><infon key="lpage">45</infon><infon key="name_0">surname:Campbell;given-names:KHS</infon><infon key="name_1">surname:Loi;given-names:P</infon><infon key="name_2">surname:Otaegui;given-names:P</infon><infon key="name_3">surname:Wilmut;given-names:I</infon><infon key="pub-id_doi">10.1530/ror.0.0010040</infon><infon key="pub-id_pmid">9414437</infon><infon key="section_type">REF</infon><infon key="source">Rev Reprod</infon><infon key="type">ref</infon><infon key="volume">1</infon><infon key="year">1996</infon><offset>30082</offset><text>Cell cycle co-ordination in embryo cloning by nuclear transfer</text></passage><passage><infon key="fpage">14984</infon><infon key="lpage">14989</infon><infon key="name_0">surname:Wakayama;given-names:T</infon><infon key="name_1">surname:Rodriguez;given-names:I</infon><infon key="name_2">surname:Perry;given-names:ACF</infon><infon key="name_3">surname:Yanagimachi;given-names:R</infon><infon key="name_4">surname:Mombaerts;given-names:P</infon><infon key="pub-id_doi">10.1073/pnas.96.26.14984</infon><infon key="pub-id_pmid">10611324</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci USA</infon><infon key="type">ref</infon><infon key="volume">96</infon><infon key="year">1999</infon><offset>30145</offset><text>Mice cloned from embryonic stem cells</text></passage><passage><infon key="fpage">324</infon><infon key="lpage">330</infon><infon key="name_0">surname:Tani;given-names:T</infon><infon key="name_1">surname:Kato;given-names:Y</infon><infon key="name_2">surname:Tsunoda;given-names:Y</infon><infon key="pub-id_pmid">11133690</infon><infon key="section_type">REF</infon><infon key="source">Biol Reprod</infon><infon key="type">ref</infon><infon key="volume">64</infon><infon key="year">2001</infon><offset>30183</offset><text>Direct exposure of chromosomes to nonactivated ovum cytoplasm is effective for bovine somatic cell nucleus reprogramming</text></passage><passage><infon key="fpage">1358</infon><infon key="lpage">1359</infon><infon key="name_0">surname:Campbell;given-names:KHS</infon><infon key="name_1">surname:Loi;given-names:P</infon><infon key="name_2">surname:Cappai;given-names:P</infon><infon key="name_3">surname:Wilmut;given-names:I</infon><infon key="section_type">REF</infon><infon key="source">Biol Reprod</infon><infon key="type">ref</infon><infon key="volume">50</infon><infon key="year">1994</infon><offset>30304</offset><text>Improved development to blastocyst of ovine nuclear transfer embryos reconstructed during the presumptive S-phase of enucleated activated oocytes</text></passage><passage><infon key="fpage">1463</infon><infon key="lpage">1471</infon><infon key="name_0">surname:Kono;given-names:T</infon><infon key="name_1">surname:Sotomaru;given-names:Y</infon><infon key="name_2">surname:Aono;given-names:F</infon><infon key="name_3">surname:Takahashi;given-names:T</infon><infon key="name_4">surname:Ogiwara;given-names:I</infon><infon key="name_5">surname:Sekizawa;given-names:F</infon><infon key="name_6">surname:Arai;given-names:T</infon><infon key="name_7">surname:Nakahara;given-names:T</infon><infon key="pub-id_doi">10.1016/0093-691X(94)90197-Q</infon><infon key="section_type">REF</infon><infon key="source">Theriogenohgy</infon><infon key="type">ref</infon><infon key="volume">41</infon><infon key="year">1994</infon><offset>30450</offset><text>Effect of ooplast activation on the development of oocytes following nucleus transfer in cattle</text></passage><passage><infon key="fpage">339</infon><infon key="lpage">343</infon><infon key="name_0">surname:Nagashima;given-names:H</infon><infon key="name_1">surname:Ashman;given-names:RJ</infon><infon key="name_2">surname:Nottle;given-names:MB</infon><infon key="pub-id_doi">10.1002/(SICI)1098-2795(199711)48:3&lt;339::AID-MRD6&gt;3.0.CO;2-S</infon><infon key="pub-id_pmid">9322245</infon><infon key="section_type">REF</infon><infon key="source">Mol Reprod Dev</infon><infon key="type">ref</infon><infon key="volume">48</infon><infon key="year">1997</infon><offset>30546</offset><text>Nuclear transfer of porcine embryos using cryopreserved delipated blastomeres as donor nuclei</text></passage><passage><infon key="fpage">657</infon><infon key="lpage">664</infon><infon key="name_0">surname:Stice;given-names:SL</infon><infon key="name_1">surname:Robl;given-names:JM</infon><infon key="pub-id_pmid">3196797</infon><infon key="section_type">REF</infon><infon key="source">Biol Reprod</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">1988</infon><offset>30640</offset><text>Nuclear reprogramming in nuclear transplant rabbit embryos</text></passage><passage><infon key="fpage">61</infon><infon key="lpage">68</infon><infon key="name_0">surname:Stice;given-names:SL</infon><infon key="name_1">surname:Keefer;given-names:CL</infon><infon key="name_2">surname:Matthews;given-names:L</infon><infon key="pub-id_pmid">8049067</infon><infon key="section_type">REF</infon><infon key="source">Mol Reprod Dev</infon><infon key="type">ref</infon><infon key="volume">38</infon><infon key="year">1994</infon><offset>30699</offset><text>Bovine nuclear transfer embryos: oocyte activation prior to blastomere fusion</text></passage><passage><infon key="fpage">1640</infon><infon key="lpage">1646</infon><infon key="name_0">surname:Miyoshi;given-names:K</infon><infon key="name_1">surname:Taguchi;given-names:Y</infon><infon key="name_2">surname:Sendai;given-names:Y</infon><infon key="name_3">surname:Hoshi;given-names:H</infon><infon key="name_4">surname:Sato;given-names:E</infon><infon key="pub-id_pmid">10819766</infon><infon key="section_type">REF</infon><infon key="source">Biol Reprod</infon><infon key="type">ref</infon><infon key="volume">62</infon><infon key="year">2000</infon><offset>30777</offset><text>Establishment of a porcine cell line from in vitro-produced blastocysts and transfer of the cells into enucleated oocytes</text></passage><passage><infon key="fpage">90</infon><infon key="lpage">100</infon><infon key="name_0">surname:Telford;given-names:NA</infon><infon key="name_1">surname:Watson;given-names:AJ</infon><infon key="name_2">surname:Schultz;given-names:GA</infon><infon key="pub-id_pmid">2189447</infon><infon key="section_type">REF</infon><infon key="source">Mol Reprod Dev</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">1990</infon><offset>30899</offset><text>Transition from maternal to embryonic control in early mammalian development: a comparison of several species</text></passage><passage><infon key="fpage">933</infon><infon key="lpage">942</infon><infon key="name_0">surname:Campbell;given-names:KHS</infon><infon key="name_1">surname:Ritchie;given-names:WA</infon><infon key="name_2">surname:Wilmut;given-names:I</infon><infon key="pub-id_pmid">8286589</infon><infon key="section_type">REF</infon><infon key="source">Biol Reprod</infon><infon key="type">ref</infon><infon key="volume">49</infon><infon key="year">1993</infon><offset>31009</offset><text>Nuclear-cytoplasmic interactions during the first cell cycle of nuclear transfer reconstructed bovine embryos: implications for deoxyribonucleic acid replication and development</text></passage><passage><infon key="fpage">862</infon><infon key="lpage">864</infon><infon key="name_0">surname:DiBerardino;given-names:MA</infon><infon key="name_1">surname:Hoffner;given-names:NJ</infon><infon key="pub-id_pmid">6600520</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">219</infon><infon key="year">1983</infon><offset>31187</offset><text>Gene reactivation in erythrocytes. Nuclear transplantation in oocytes and eggs of Rana</text></passage><passage><infon key="fpage">8231</infon><infon key="lpage">8234</infon><infon key="name_0">surname:DiBerardino;given-names:MA</infon><infon key="name_1">surname:Orr Hoffner;given-names:N</infon><infon key="name_2">surname:McKinnell;given-names:RG</infon><infon key="pub-id_pmid">3490665</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci USA</infon><infon key="type">ref</infon><infon key="volume">83</infon><infon key="year">1986</infon><offset>31274</offset><text>Feeding tadpoles cloned from Rana erythrocyte nuclei</text></passage><passage><infon key="fpage">93</infon><infon key="lpage">112</infon><infon key="name_0">surname:Gurdon;given-names:JB</infon><infon key="name_1">surname:Laskey;given-names:RA</infon><infon key="name_2">surname:Reeves;given-names:OR</infon><infon key="pub-id_pmid">1102625</infon><infon key="section_type">REF</infon><infon key="source">J Embryol Exp Morphol</infon><infon key="type">ref</infon><infon key="volume">34</infon><infon key="year">1975</infon><offset>31327</offset><text>The developmental capacity of nuclei transplanted from keratinized skin cells of adult frogs</text></passage><passage><infon key="fpage">271</infon><infon key="lpage">284</infon><infon key="name_0">surname:Brun;given-names:RB</infon><infon key="pub-id_pmid">680363</infon><infon key="section_type">REF</infon><infon key="source">Dev Biol</infon><infon key="type">ref</infon><infon key="volume">65</infon><infon key="year">1978</infon><offset>31420</offset><text>Developmental capacities of Xenopus eggs, provided with erythrocyte or erythroblast nuclei from adults</text></passage><passage><infon key="fpage">407</infon><infon key="lpage">411</infon><infon key="name_0">surname:Tsunoda;given-names:Y</infon><infon key="name_1">surname:Tokunaga;given-names:T</infon><infon key="name_2">surname:Uchida;given-names:T</infon><infon key="pub-id_pmid">2632230</infon><infon key="section_type">REF</infon><infon key="source">Development</infon><infon key="type">ref</infon><infon key="volume">107</infon><infon key="year">1989</infon><offset>31523</offset><text>Nuclear transplantation of male germ cells in the mouse</text></passage><passage><infon key="fpage">355</infon><infon key="lpage">358</infon><infon key="name_0">surname:Prather;given-names:RS</infon><infon key="name_1">surname:Sims;given-names:MM</infon><infon key="name_2">surname:First;given-names:NL</infon><infon key="pub-id_pmid">2394976</infon><infon key="section_type">REF</infon><infon key="source">J Exp Zool</infon><infon key="type">ref</infon><infon key="volume">255</infon><infon key="year">1990</infon><offset>31579</offset><text>Nuclear transplantation in the pig embryo: nuclear swelling</text></passage><passage><infon key="fpage">559</infon><infon key="lpage">570</infon><infon key="name_0">surname:Uhm;given-names:SJ</infon><infon key="name_1">surname:Chung;given-names:HM</infon><infon key="name_2">surname:Kirn;given-names:C</infon><infon key="name_3">surname:Shim;given-names:H</infon><infon key="name_4">surname:Kirn;given-names:NH</infon><infon key="name_5">surname:Lee;given-names:HT</infon><infon key="name_6">surname:Chung;given-names:KS</infon><infon key="pub-id_doi">10.1016/S0093-691X(00)00371-X</infon><infon key="pub-id_pmid">11071130</infon><infon key="section_type">REF</infon><infon key="source">Theriogenology</infon><infon key="type">ref</infon><infon key="volume">54</infon><infon key="year">2000</infon><offset>31639</offset><text>In vitro development of porcine enucleated oocytes reconstructed by the transfer of porcine fetal fibroblasts and cumulus cells</text></passage><passage><infon key="fpage">125</infon><infon key="lpage">134</infon><infon key="name_0">surname:Prather;given-names:RS</infon><infon key="name_1">surname:First;given-names:NL</infon><infon key="pub-id_pmid">2213705</infon><infon key="section_type">REF</infon><infon key="source">J Reprod Fertil Suppl</infon><infon key="type">ref</infon><infon key="volume">41</infon><infon key="year">1990</infon><offset>31767</offset><text>Cloning embryos by nuclear transfer</text></passage><passage><infon key="fpage">455</infon><infon key="lpage">465</infon><infon key="name_0">surname:Collas;given-names:P</infon><infon key="name_1">surname:Robl;given-names:JM</infon><infon key="pub-id_pmid">1782294</infon><infon key="section_type">REF</infon><infon key="source">Biol Reprod</infon><infon key="type">ref</infon><infon key="volume">45</infon><infon key="year">1991</infon><offset>31803</offset><text>Relationship between nuclear remodeling and development in nuclear transplant rabbit embryos</text></passage><passage><infon key="fpage">159</infon><infon key="lpage">167</infon><infon key="name_0">surname:Hyttel;given-names:P</infon><infon key="name_1">surname:Prochazka;given-names:R</infon><infon key="name_2">surname:Smith;given-names:S</infon><infon key="name_3">surname:Kanka;given-names:J</infon><infon key="name_4">surname:Greve;given-names:T</infon><infon key="pub-id_pmid">7505526</infon><infon key="section_type">REF</infon><infon key="source">Acta Vet Scand</infon><infon key="type">ref</infon><infon key="volume">34</infon><infon key="year">1993</infon><offset>31896</offset><text>RNA synthesis in porcine blastomere nuclei introduced into in vitro matured ooplasm</text></passage><passage><infon key="fpage">75</infon><infon key="lpage">94</infon><infon key="name_0">surname:Niemann;given-names:H</infon><infon key="name_1">surname:Reichelt;given-names:B</infon><infon key="pub-id_pmid">8145216</infon><infon key="section_type">REF</infon><infon key="source">J Reprod Fertil Suppl</infon><infon key="type">ref</infon><infon key="volume">48</infon><infon key="year">1993</infon><offset>31980</offset><text>Manipulating early pig embryos</text></passage><passage><infon key="fpage">639</infon><infon key="lpage">644</infon><infon key="name_0">surname:Liu;given-names:L</infon><infon key="name_1">surname:Moor;given-names:RM</infon><infon key="name_2">surname:Laurie;given-names:S</infon><infon key="name_3">surname:Notarianni;given-names:E</infon><infon key="pub-id_pmid">8619962</infon><infon key="section_type">REF</infon><infon key="source">Int J Dev Biol</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">1995</infon><offset>32011</offset><text>Nuclear remodelling and early development in cryopreserved, porcine primordial germ cells following nuclear transfer into in vitro-matured oocytes</text></passage><passage><infon key="fpage">443</infon><infon key="lpage">450</infon><infon key="name_0">surname:Sun;given-names:QY</infon><infon key="name_1">surname:Breitbart;given-names:H</infon><infon key="name_2">surname:Schatten;given-names:H</infon><infon key="pub-id_doi">10.1071/RD00014</infon><infon key="pub-id_pmid">11101281</infon><infon key="section_type">REF</infon><infon key="source">Reprod Fertil Dev</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">1999</infon><offset>32158</offset><text>Role of the MAPK cascade in mammalian germ cells</text></passage><passage><infon key="fpage">1017</infon><infon key="lpage">1025</infon><infon key="name_0">surname:Verlhac;given-names:MH</infon><infon key="name_1">surname:Kubiak;given-names:JZ</infon><infon key="name_2">surname:Clarke;given-names:HJ</infon><infon key="name_3">surname:Maro;given-names:BH</infon><infon key="pub-id_pmid">7600950</infon><infon key="section_type">REF</infon><infon key="source">Development</infon><infon key="type">ref</infon><infon key="volume">120</infon><infon key="year">1994</infon><offset>32207</offset><text>Microtubule and chromatin behavior follow MAP kinase activity but not MPF activity during meiosis in mouse oocyte</text></passage><passage><infon key="fpage">265</infon><infon key="lpage">271</infon><infon key="name_0">surname:Inoue;given-names:M</infon><infon key="name_1">surname:Naito;given-names:K</infon><infon key="name_2">surname:Aoki;given-names:F</infon><infon key="name_3">surname:Toyoda;given-names:Y</infon><infon key="name_4">surname:Sato;given-names:E</infon><infon key="pub-id_pmid">8903796</infon><infon key="section_type">REF</infon><infon key="source">Zygote</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">1995</infon><offset>32321</offset><text>Activation of mitogen-activated protein kinase during meiotic maturation in porcine oocytes</text></passage><passage><infon key="fpage">879</infon><infon key="lpage">889</infon><infon key="name_0">surname:Sun;given-names:QY</infon><infon key="name_1">surname:Lai;given-names:L</infon><infon key="name_2">surname:Park;given-names:KW</infon><infon key="name_3">surname:Kuhholzer;given-names:B</infon><infon key="name_4">surname:Prather;given-names:RS</infon><infon key="name_5">surname:Schatten;given-names:H</infon><infon key="pub-id_pmid">11207204</infon><infon key="section_type">REF</infon><infon key="source">Biol Reprod</infon><infon key="type">ref</infon><infon key="volume">64</infon><infon key="year">2001</infon><offset>32413</offset><text>Dynamic events are differently mediated by microfilaments, microtubules, and mitogen-activated protein kinase during porcine oocyte maturation and fertilization in vitro</text></passage><passage><infon key="fpage">1300</infon><infon key="lpage">1302</infon><infon key="name_0">surname:McGrath;given-names:J</infon><infon key="name_1">surname:Solter;given-names:D</infon><infon key="pub-id_pmid">6857250</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">220</infon><infon key="year">1998</infon><offset>32583</offset><text>Nuclear transplantation in the mouse embryo by microsurgery and cell fusion</text></passage><passage><infon key="fpage">355</infon><infon key="lpage">362</infon><infon key="name_0">surname:McGrath;given-names:J</infon><infon key="name_1">surname:Solter;given-names:D</infon><infon key="pub-id_pmid">6141214</infon><infon key="section_type">REF</infon><infon key="source">J Exp Zool</infon><infon key="type">ref</infon><infon key="volume">228</infon><infon key="year">1993</infon><offset>32659</offset><text>Nuclear transplantation in mouse embryos</text></passage><passage><infon key="fpage">108</infon><infon key="lpage">109</infon><infon key="name_0">surname:Wakayama;given-names:T</infon><infon key="name_1">surname:Tateno;given-names:H</infon><infon key="name_2">surname:Mombaerts;given-names:P</infon><infon key="name_3">surname:Yanagimachi;given-names:R</infon><infon key="pub-id_doi">10.1038/72749</infon><infon key="pub-id_pmid">10655051</infon><infon key="section_type">REF</infon><infon key="source">Nature Genet</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">2000</infon><offset>32700</offset><text>Nuclear transfer into mouse zygotes</text></passage><passage><infon key="fpage">63</infon><infon key="lpage">65</infon><infon key="name_0">surname:Willadsen;given-names:SM</infon><infon key="pub-id_pmid">3951549</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">320</infon><infon key="year">1986</infon><offset>32736</offset><text>Nuclear transplantation in sheep embryos</text></passage><passage><infon key="fpage">510</infon><infon key="lpage">515</infon><infon key="name_0">surname:Wang;given-names:WH</infon><infon key="name_1">surname:Abeydeera;given-names:LR</infon><infon key="name_2">surname:Okuda;given-names:K</infon><infon key="name_3">surname:Niwa;given-names:K</infon><infon key="pub-id_pmid">8167222</infon><infon key="section_type">REF</infon><infon key="source">Biol Reprod</infon><infon key="type">ref</infon><infon key="volume">50</infon><infon key="year">1994</infon><offset>32777</offset><text>Penetration of porcine oocytes during maturation in vitro by cryopreserved, ejaculated spermatozoa</text></passage><passage><infon key="fpage">175</infon><infon key="lpage">184</infon><infon key="name_0">surname:Miyoshi;given-names:K</infon><infon key="name_1">surname:Saeki;given-names:K</infon><infon key="name_2">surname:Sato;given-names:E</infon><infon key="pub-id_doi">10.1089/15204550045473510.1089/152045500454735</infon><infon key="pub-id_pmid">16218854</infon><infon key="section_type">REF</infon><infon key="source">Cloning</infon><infon key="type">ref</infon><infon key="volume">2</infon><infon key="year">2000</infon><offset>32876</offset><text>Improvement in development of porcine embryos reconstituted with cells from blastocyst-derived cell lines and enucleated oocytes by optimization of reconstruction methods</text></passage><passage><infon key="fpage">242</infon><infon key="lpage">247</infon><infon key="name_0">surname:Hsu;given-names:CJ</infon><infon key="name_1">surname:Holmes;given-names:SD</infon><infon key="name_2">surname:Hammond;given-names:JM</infon><infon key="pub-id_pmid">3498484</infon><infon key="section_type">REF</infon><infon key="source">Biochem Biophys Res Commun</infon><infon key="type">ref</infon><infon key="volume">147</infon><infon key="year">1987</infon><offset>33047</offset><text>Ovarian epidermal growth factor-like activity. Concentrations in porcine follicular fluid during follicular enlargement</text></passage><passage><infon key="fpage">189</infon><infon key="lpage">201</infon><infon key="name_0">surname:Younis;given-names:AI</infon><infon key="name_1">surname:Brackett;given-names:BG</infon><infon key="name_2">surname:Fayrer-Hosken;given-names:RA</infon><infon key="pub-id_pmid">2499525</infon><infon key="section_type">REF</infon><infon key="source">Gamete Res</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">1989</infon><offset>33167</offset><text>Influence of serum and hormones on bovine oocyte maturation and fertilization in vitro</text></passage><passage><infon key="fpage">621</infon><infon key="lpage">627</infon><infon key="name_0">surname:Ainsworth;given-names:L</infon><infon key="name_1">surname:Tsang;given-names:BK</infon><infon key="name_2">surname:Downey;given-names:BR</infon><infon key="name_3">surname:Marcus;given-names:GJ</infon><infon key="name_4">surname:Armstrong;given-names:DT</infon><infon key="pub-id_pmid">7448265</infon><infon key="section_type">REF</infon><infon key="source">Biol Reprod</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">1980</infon><offset>33254</offset><text>Interrelationships between follicular fluid steroid levels, gonadotropic stimuli, and oocyte maturation during preovulatory development of porcine follicles</text></passage><passage><infon key="fpage">648</infon><infon key="lpage">655</infon><infon key="name_0">surname:Ding;given-names:J</infon><infon key="name_1">surname:Foxcroft;given-names:GR</infon><infon key="pub-id_pmid">1391353</infon><infon key="section_type">REF</infon><infon key="source">Biol Reprod</infon><infon key="type">ref</infon><infon key="volume">47</infon><infon key="year">1992</infon><offset>33411</offset><text>Follicular heterogeneity and oocyte maturation in vitro in pigs</text></passage><passage><infon key="fpage">1316</infon><infon key="lpage">1320</infon><infon key="name_0">surname:Abeydeera;given-names:LR</infon><infon key="name_1">surname:Wang;given-names:WH</infon><infon key="name_2">surname:Prather;given-names:RS</infon><infon key="name_3">surname:Day;given-names:BN</infon><infon key="pub-id_pmid">9603270</infon><infon key="section_type">REF</infon><infon key="source">Biol Reprod</infon><infon key="type">ref</infon><infon key="volume">58</infon><infon key="year">1998</infon><offset>33475</offset><text>Maturation in vitro of pig oocytes in protein-free culture media: fertilization and subsequent embryo development in vitro</text></passage><passage><infon key="fpage">787</infon><infon key="lpage">797</infon><infon key="name_0">surname:Abeydeera;given-names:LR</infon><infon key="name_1">surname:Wang;given-names:WH</infon><infon key="name_2">surname:Cantley;given-names:TC</infon><infon key="name_3">surname:Rieke;given-names:A</infon><infon key="name_4">surname:Murphy;given-names:CN</infon><infon key="name_5">surname:Prather;given-names:RS</infon><infon key="name_6">surname:Day;given-names:BN</infon><infon key="pub-id_doi">10.1016/S0093-691X(00)00390-3</infon><infon key="pub-id_pmid">11101038</infon><infon key="section_type">REF</infon><infon key="source">Theriogenology</infon><infon key="type">ref</infon><infon key="volume">54</infon><infon key="year">2000</infon><offset>33598</offset><text>Development and viability of pig oocytes matured in a protein-free medium containing epidermal growth factor</text></passage><passage><infon key="fpage">15</infon><infon key="lpage">21</infon><infon key="name_0">surname:Koo;given-names:DB</infon><infon key="name_1">surname:Kang;given-names:YK</infon><infon key="name_2">surname:Choi;given-names:YH</infon><infon key="name_3">surname:Park;given-names:JS</infon><infon key="name_4">surname:Kirn;given-names:HN</infon><infon key="name_5">surname:Kim;given-names:T</infon><infon key="name_6">surname:Lee;given-names:KK</infon><infon key="name_7">surname:Han;given-names:YM</infon><infon key="pub-id_doi">10.1002/1098-2795(200101)58:1&lt;15::AID-MRD3&gt;3.0.CO;2-Y</infon><infon key="pub-id_pmid">11144215</infon><infon key="section_type">REF</infon><infon key="source">Mol Reprod Dev</infon><infon key="type">ref</infon><infon key="volume">58</infon><infon key="year">2001</infon><offset>33707</offset><text>Developmental potential and transgene expression of porcine nuclear transfer embryos using somatic cells</text></passage><passage><infon key="fpage">55</infon><infon key="lpage">62</infon><infon key="name_0">surname:Tao;given-names:T</infon><infon key="name_1">surname:Boquest;given-names:AC</infon><infon key="name_2">surname:Machaty;given-names:Z</infon><infon key="name_3">surname:Petersen;given-names:AL</infon><infon key="name_4">surname:Day;given-names:BN</infon><infon key="name_5">surname:Prather;given-names:RS</infon><infon key="pub-id_doi">10.1089/1520455995002009410.1089/15204559950020094</infon><infon key="pub-id_pmid">16218830</infon><infon key="section_type">REF</infon><infon key="source">Cloning</infon><infon key="type">ref</infon><infon key="volume">1</infon><infon key="year">1999</infon><offset>33812</offset><text>Development of pig embryos by nuclear transfer of cultured fibroblast cells</text></passage><passage><infon key="fpage">133</infon><infon key="lpage">141</infon><infon key="name_0">surname:Tao;given-names:T</infon><infon key="name_1">surname:Machaty;given-names:Z</infon><infon key="name_2">surname:Boquest;given-names:AC</infon><infon key="name_3">surname:Day;given-names:BN</infon><infon key="name_4">surname:Prather;given-names:RS</infon><infon key="pub-id_doi">10.1016/S0378-4320(99)00037-8</infon><infon key="pub-id_pmid">10463400</infon><infon key="section_type">REF</infon><infon key="source">Anim Reprod Sci</infon><infon key="type">ref</infon><infon key="volume">56</infon><infon key="year">1999</infon><offset>33888</offset><text>Development of pig embryos reconstructed by microinjection of cultured fetal fibroblast cells into in vitro matured oocytes</text></passage><passage><infon key="fpage">986</infon><infon key="lpage">992</infon><infon key="name_0">surname:Koo;given-names:DB</infon><infon key="name_1">surname:Kang;given-names:YK</infon><infon key="name_10">surname:Han;given-names:YM</infon><infon key="name_2">surname:Choi;given-names:YH</infon><infon key="name_3">surname:Park;given-names:JS</infon><infon key="name_4">surname:Han;given-names:SK</infon><infon key="name_5">surname:Park;given-names:IY</infon><infon key="name_6">surname:Kim;given-names:SU</infon><infon key="name_7">surname:Lee;given-names:KK</infon><infon key="name_8">surname:Son;given-names:DS</infon><infon key="name_9">surname:Chang;given-names:WK</infon><infon key="pub-id_pmid">10993818</infon><infon key="section_type">REF</infon><infon key="source">Biol Reprod</infon><infon key="type">ref</infon><infon key="volume">63</infon><infon key="year">2000</infon><offset>34012</offset><text>In vitro development of reconstructed porcine oocytes after somatic cell nuclear transfer</text></passage><passage><infon key="fpage">145</infon><infon key="lpage">148</infon><infon key="name_0">surname:Kuhholzer;given-names:B</infon><infon key="name_1">surname:Tao;given-names:T</infon><infon key="name_2">surname:Machaty;given-names:Z</infon><infon key="name_3">surname:Hawley;given-names:RJ</infon><infon key="name_4">surname:Greenstein;given-names:JL</infon><infon key="name_5">surname:Day;given-names:BN</infon><infon key="name_6">surname:Prather;given-names:RS</infon><infon key="pub-id_doi">10.1002/(SICI)1098-2795(200006)56:2&lt;145::AID-MRD4&gt;3.0.CO;2-8</infon><infon key="pub-id_pmid">10813845</infon><infon key="section_type">REF</infon><infon key="source">Mol Reprod Dev</infon><infon key="type">ref</infon><infon key="volume">56</infon><infon key="year">2000</infon><offset>34102</offset><text>Production of transgenic porcine blastocysts by nuclear transfer</text></passage><passage><infon key="fpage">262</infon><infon key="lpage">269</infon><infon key="name_0">surname:Verma;given-names:PJ</infon><infon key="name_1">surname:Du;given-names:ZT</infon><infon key="name_2">surname:Crocker;given-names:L</infon><infon key="name_3">surname:Faast;given-names:R</infon><infon key="name_4">surname:Grupen;given-names:CG</infon><infon key="name_5">surname:McIlfatrick;given-names:SM</infon><infon key="name_6">surname:Ashman;given-names:RJ</infon><infon key="name_7">surname:Lyons;given-names:IG</infon><infon key="name_8">surname:Nottle;given-names:MB</infon><infon key="pub-id_doi">10.1002/1098-2795(200011)57:3&lt;262::AID-MRD8&gt;3.0.CO;2-X</infon><infon key="pub-id_pmid">11013434</infon><infon key="section_type">REF</infon><infon key="source">Mol Reprod Dev</infon><infon key="type">ref</infon><infon key="volume">57</infon><infon key="year">2000</infon><offset>34167</offset><text>In vitro development of porcine nuclear transfer embryos constructed using fetal fibroblasts</text></passage><passage><infon key="fpage">331</infon><infon key="lpage">337</infon><infon key="name_0">surname:Uhm;given-names:SJ</infon><infon key="name_1">surname:Kim;given-names:NH</infon><infon key="name_2">surname:Kim;given-names:T</infon><infon key="name_3">surname:Chung;given-names:HM</infon><infon key="name_4">surname:Chung;given-names:KH</infon><infon key="name_5">surname:Lee;given-names:HT</infon><infon key="name_6">surname:Chung;given-names:KS</infon><infon key="pub-id_doi">10.1002/1098-2795(200012)57:4&lt;331::AID-MRD4&gt;3.0.CO;2-7</infon><infon key="pub-id_pmid">11066061</infon><infon key="section_type">REF</infon><infon key="source">Mol Reprod Dev</infon><infon key="type">ref</infon><infon key="volume">57</infon><infon key="year">2000</infon><offset>34260</offset><text>Expression of enhanced green fluorescent protein (EGFP) and neomycin resistant (Neo(R)) genes in porcine embryos following nuclear transfer with porcine fetal fibroblasts transfected by retrovirus vector</text></passage><passage><infon key="fpage">493</infon><infon key="lpage">497</infon><infon key="name_0">surname:Tervit;given-names:HR</infon><infon key="name_1">surname:Whittingham;given-names:DG</infon><infon key="name_2">surname:Rowson;given-names:LEA</infon><infon key="section_type">REF</infon><infon key="source">J Reprod Ferttil</infon><infon key="type">ref</infon><infon key="volume">30</infon><infon key="year">1972</infon><offset>34464</offset><text>Successful culture in vitro of sheep and cattle ova</text></passage><passage><infon key="fpage">165</infon><infon key="lpage">182</infon><infon key="name_0">surname:Zimmemiann;given-names:U</infon><infon key="name_1">surname:Vienken;given-names:J</infon><infon key="pub-id_pmid">7050391</infon><infon key="section_type">REF</infon><infon key="source">J Membr Biol</infon><infon key="type">ref</infon><infon key="volume">67</infon><infon key="year">1982</infon><offset>34516</offset><text>Electric field-induced cell-to-cell fusion</text></passage><passage><infon key="fpage">269</infon><infon key="lpage">275</infon><infon key="name_0">surname:Gandhi;given-names:AP</infon><infon key="name_1">surname:Lane;given-names:M</infon><infon key="name_2">surname:Gardner;given-names:DK</infon><infon key="name_3">surname:Krisher;given-names:RL</infon><infon key="pub-id_doi">10.1002/1098-2795(200103)58:3&lt;269::AID-MRD4&gt;3.0.CO;2-L</infon><infon key="pub-id_pmid">11170267</infon><infon key="section_type">REF</infon><infon key="source">Mol Reprod Dev</infon><infon key="type">ref</infon><infon key="volume">58</infon><infon key="year">2001</infon><offset>34559</offset><text>Substrate utilization in porcine embryos cultured in NCSU23 and G1.2/G2.2 sequential culture media</text></passage></document></collection>